Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Nov 25;18(1):561.
doi: 10.1186/s13256-024-04909-1.

A successful application of information technologies in the treatment of multiple sclerosis: a case report

Naylya Djumaeva  1
Affiliations
Case Reports

A successful application of information technologies in the treatment of multiple sclerosis: a case report

Naylya Djumaeva. J Med Case Rep. .

Abstract

Background: Multiple sclerosis is a chronic disease of the central nervous system characterized by inflammation, neurodegeneration, and failure of the central nervous system's repair mechanisms. The role of infectious agents against the background of genetic predisposition is currently considered a possible pathogenesis factor of this disease.

Case presentation: We report the case of a 52-year-old white (Russian) female musician with 15-year history of relapsing-remitting multiple sclerosis who had repeatedly received conventional therapy without much benefit. In 2017, she was admitted to the outpatient department of the Institute of Virology, where she was treated with erythromycin and acyclovir (tablet forms), which were not applied in the traditional way but through the "device for transfer of information from the drug to the human body." The received effect led to suppression of the disease activity, a significant reduction in the symptoms of the disease, prevention of further increase in neurological manifestations of the disease, and improvement in the dynamics of the manifestation of the disease according to brain magnetic resonance imaging.

Conclusion: The described case report is innovative and presents for the first time the results of a noninvasive approach to the treatment of a patient with multiple sclerosis in whom information about various medications was introduced into different parts of the body, including the brain. The results obtained may indicate a possible role of infectious agents in the genesis of multiple sclerosis. It indicates a potential impact on them by using a "device for transfer of information from the drug to the human body." The study was conducted in accordance with the principles of the Declaration of Helsinki. It was approved by the Institutional Review Board of the Research Institute of Virology of Uzbekistan (no. 12/8-1500, 1/3/2017).

Keywords: Acyclovir; Device for remote transfer of information from a drug to the human body; Erythromycin; MRI; Medicament testing; Multiply sclerosis.

PubMed Disclaimer

Conflict of interest statement

Declarations. Consent for publication: Written informed consent was obtained from the patient's legal guardian to publish this case report of a 59-year-old female patient and any accompanying images. A copy of the written consent is available for review by the Editor-in- Chief of this journal. Competing interests: The author declares no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Fig. 1
Fig. 1
Schematic of the device used in the study
Fig. 2
Fig. 2
Localization of demyelinating lesions in different parts of the patient’s brain
See this image and copyright information in PMC

References

    1. Jakumowski D, Bittner S, Zivadinov R, et al. Multiply sclerosis. Lancet. 2024;403(10432):183–202. 10.1016/S0140-6736(23)01473-3. - PubMed
    1. Pérez CA, Cuascut FX, Hutton GJ. Immunopathogenesis, diagnosis, and treatment of multiple sclerosis: a clinical update. Neurol Clin. 2023;41(1):87–106. 10.1016/j.ncl.2022.05.004. - PubMed
    1. Faissner S, Gold R. Progressive multiple sclerosis: latest therapeutic developments and future directions. Ther Advan in Neurol Dis. 2019;12:1756286419878323. 10.1177/1756286419878323. - PMC - PubMed
    1. Domínguez-Mozo MI, López-Lozano L, Pérez-Pérez S, García-Martínez Á, et al. Epstein-Barr virus and multiple sclerosis in a Spanish cohort: a two-years longitudinal study. Front Immunol. 2022;13: 991662. 10.3389/fimmu.2022.991662. - PMC - PubMed
    1. Libbey JE, Cusick MF, Fujinami RS. Role of pathogens in multiple sclerosis. Int Rev Immunol. 2014;33(4):266–83. 10.3109/08830185.2013.823422. - PMC - PubMed

Publication types

LinkOut - more resources